Department of Health Policy

Insurance claims for gender-affirming therapies have increased, but filling prescriptions without insurance may be more affordable, new study finds

Vanderbilt researchers found that both gender dysphoria diagnoses and use of gender therapies have increased substantially between 2013 and 2019.

Aliyu named director of Vanderbilt Institute for Global Health

Renowned physician-epidemiologist Muktar Aliyu, MBBS, MPH, DrPH, who is the associate director for Research with the Vanderbilt Institute for Global Health (VIGH), has been named the new director of the institute, beginning July 1.

Filling multiple opioid prescriptions after childbirth associated with maternal death risk

In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.

Capacity-building grant trains biostatisticians in West Africa

The Vanderbilt Institute for Global Health, Vanderbilt Department of Biostatistics, and Aminu Kano Teaching Hospital (AKTH) have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa. 

New study illustrates how much it would cost for cancer drugs covered under Medicare Part D

A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit.

Study compares moral injury in health care workers and veterans

A study comparing 618 military veterans who deployed to a combat zone after Sept. 11, 2001, and 2,099 health care workers (HCWs) working during the COVID-19 pandemic found similar levels of potential moral injury (PMI), with 46.1% of veterans and 50.7% of HCWs reporting PMI.

1 2 3 4 5 6 15